Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (18902)	2/18/1999 2:06:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, Regardless of the short term pain, I am in this until the very end. I don't feel that the current price is justified based on the facts we have looking out into the future. Andreas has so eloquently pointed out things we already knew after January 28th's cc. The bottom line is that as things stand TODAY and TOMORROW, Vivus will always be dependent on its profitability based on OTHER companies abilities to sell the product. This is not some sort of new phenomena and it is in fact the way it works with small biotech companies. The fact of the matter is that the United States is the largest pharmaceutical market in the world and that being said, it is paramount that Wilson signs a deal that protects the long term future of the company. A crummy deal will mean a stock price that may recover somewhat but never to levels as seen in 1996/97. I don't know what goes on behind closed doors and I don't know what types of offers are or are not on the table but I currently am confident that we will have a partner signed in the first 1/2 of 1999. In the mean time we must bite the bullet and take the pain.